Selected article for: "PCR analysis and viral PCR nucleic acid"

Author: Mirvish, Ezra D.; Shuda, Masahiro
Title: Strategies for Human Tumor Virus Discoveries: From Microscopic Observation to Digital Transcriptome Subtraction
  • Cord-id: e8cihwn1
  • Document date: 2016_5_13
  • ID: e8cihwn1
    Snippet: Over 20% of human cancers worldwide are associated with infectious agents, including viruses, bacteria, and parasites. Various methods have been used to identify human tumor viruses, including electron microscopic observations of viral particles, immunologic screening, cDNA library screening, nucleic acid hybridization, consensus PCR, viral DNA array chip, and representational difference analysis. With the Human Genome Project, a large amount of genetic information from humans and other organism
    Document: Over 20% of human cancers worldwide are associated with infectious agents, including viruses, bacteria, and parasites. Various methods have been used to identify human tumor viruses, including electron microscopic observations of viral particles, immunologic screening, cDNA library screening, nucleic acid hybridization, consensus PCR, viral DNA array chip, and representational difference analysis. With the Human Genome Project, a large amount of genetic information from humans and other organisms has accumulated over the last decade. Utilizing the available genetic databases, Feng et al. (2007) developed digital transcriptome subtraction (DTS), an in silico method to sequentially subtract human sequences from tissue or cellular transcriptome, and discovered Merkel cell polyomavirus (MCV) from Merkel cell carcinoma. Here, we review the background and methods underlying the human tumor virus discoveries and explain how DTS was developed and used for the discovery of MCV.

    Search related documents:
    Co phrase search for related documents
    • acid hybridization and acute respiratory syndrome: 1, 2, 3, 4
    • acute infection and additional evidence: 1, 2, 3, 4, 5
    • acute infection and additional experiment: 1
    • acute infection and liver spleen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute infection and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • acute infection and lymphoproliferative disease: 1
    • acute infection and lymphoproliferative disorder: 1
    • acute lymphoproliferative disease and lung cancer: 1
    • acute lymphoproliferative disease and lymphoproliferative disease: 1, 2, 3
    • acute lymphoproliferative disease and lymphoproliferative disorder: 1, 2
    • acute lymphoproliferative disease development and lymphoproliferative disease: 1
    • acute lymphoproliferative disease development and lymphoproliferative disorder: 1
    • acute respiratory syndrome and additional evidence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • acute respiratory syndrome and liver spleen: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38
    • acute respiratory syndrome and liver spleen tissue: 1
    • acute respiratory syndrome and lt expression: 1
    • acute respiratory syndrome and lung cancer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • acute respiratory syndrome and lymphoproliferative disease: 1, 2, 3
    • acute respiratory syndrome and lymphoproliferative disorder: 1